Pharmacologic cholinesterase inhibition improves survival in experimental sepsis*
Stefan Hofer(Westpfalz Klinikum), Markus A. Weigand(Heidelberg University), Jens Werner(LMU Klinikum), Martina Brueckmann, Christoph Eisenbach(University of Mannheim), Lutz Schneider(University of Mannheim), Alexander H. Dalpke(Heidelberg University), Jens Encke(University of Mannheim), Angelika Bierhaus(Heidelberg University), Peter P. Nawroth(Technische Universität Dresden), Sven Mautner(University of Mannheim), Peter H. Krammer(Slovak Academy of Sciences), Moritz N. Wente(Heidelberg University), Wolfgang Stremmel(University Hospital Heidelberg), Konrad A. Bode(University of Mannheim), Eike Martin(Heidelberg University), Ivan Krešimir Lukić(University of Split)
Cited by 161
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k